SI-BONE (SIBN) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

SIBN Stock Forecast

SI-BONE stock forecast is as follows: an average price target of $20.00 (represents a 62.73% upside from SIBN’s last price of $12.29) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.

SIBN Price Target

The average price target for SI-BONE (SIBN) is $20.00 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $25.00 to $18.00. This represents a potential 62.73% upside from SIBN's last price of $12.29.

SIBN Analyst Ratings

Buy

According to 8 Wall Street analysts, SI-BONE's rating consensus is 'Buy'. The analyst rating breakdown for SIBN stock is 0 'Strong Buy' (0.00%), 6 'Buy' (75.00%), 2 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

SI-BONE Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 06, 2024	Samuel Brodovsky	Truist Financial	-	-	28.21%	46.46%
Aug 06, 2024	David Saxon	Needham	-	-	32.31%	54.60%
Mar 28, 2024	Matt O'Brien	Piper Sandler	-	-	58.03%	103.42%
Jul 12, 2023	David Saxon	Needham	-	-	18.83%	160.37%
Jan 06, 2023		Morgan Stanley	-	-	43.08%	46.46%
Dec 20, 2022		Truist Financial	-	-	44.50%	38.32%
May 16, 2022	Drew Ranieri	Morgan Stanley	-	-	76.00%	79.01%

Row per page

Go to

The latest SI-BONE stock forecast, released on Aug 06, 2024 by Samuel Brodovsky from Truist Financial, set a price target of $18.00, which represents a 28.21% increase from the stock price at the time of the forecast ($14.04), and a 46.46% increase from SIBN last price ($12.29).

SI-BONE Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	3
Avg Price Target	-	-	$20.67
Last Closing Price	$12.29	$12.29	$12.29
Upside/Downside	-100.00%	-100.00%	68.19%

In the current month, the average price target of SI-BONE stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to SI-BONE's last price of $12.29. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 03, 2024	Piper Sandler	Overweight	Overweight	Hold
Aug 06, 2024	Needham	Buy	Buy	Hold
May 07, 2024	Needham	Underperform	Underperform	Hold
May 07, 2024	Piper Sandler	Buy	Buy	Hold
May 07, 2024	Bank of America Securities	Neutral	Neutral	Hold
Mar 28, 2024	Piper Sandler	Buy	Buy	Hold
Mar 28, 2024	Piper Sandler		Overweight	Initialise
Feb 27, 2024	Truist Financial	Buy	Buy	Hold
Dec 22, 2023	Needham	Buy	Buy	Hold
Nov 07, 2023	Cantor Fitzgerald	Overweight	Overweight	Hold

Row per page

Go to

SI-BONE's last stock rating was published by Piper Sandler on Oct 03, 2024. The company gave SIBN a "Overweight" rating, the same as its previous rate.

SI-BONE Financial Forecast

SI-BONE Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$34.01M	$33.30M	$32.71M	$31.95M	$26.43M	$25.59M	$22.44M	$25.23M	$22.29M	$22.19M	$20.44M	$22.14M	$20.37M	$14.05M	$16.82M	$19.81M	$16.18M
Avg Forecast	$60.73M	$55.73M	$55.06M	$54.21M	$54.17M	$47.75M	$46.93M	$44.69M	$46.89M	$40.49M	$39.10M	$36.49M	$37.92M	$32.38M	$31.21M	$29.17M	$31.50M	$26.43M	$25.17M	$21.87M	$24.71M	$22.49M	$21.74M	$18.93M	$22.08M	$16.51M	$8.78M	$17.87M	$19.29M	$16.27M
High Forecast	$61.53M	$56.47M	$55.79M	$54.93M	$54.88M	$48.38M	$47.55M	$45.44M	$47.16M	$40.49M	$39.10M	$36.49M	$38.42M	$32.38M	$31.62M	$29.56M	$31.92M	$26.43M	$25.17M	$21.87M	$24.71M	$22.49M	$21.74M	$18.93M	$22.08M	$16.51M	$8.78M	$17.87M	$19.29M	$16.27M
Low Forecast	$60.23M	$55.27M	$54.60M	$53.76M	$53.72M	$47.36M	$46.54M	$43.94M	$46.73M	$40.48M	$39.10M	$36.49M	$37.60M	$32.38M	$30.95M	$28.93M	$31.24M	$26.43M	$25.17M	$21.87M	$24.71M	$22.49M	$21.74M	$18.93M	$22.08M	$16.51M	$8.78M	$17.87M	$19.29M	$16.27M
# Analysts	1	1	1	1	1	1	1	3	6	3	2	2	4	2	2	2	1	1	1	1	2	2	2	6	9	9	9	9	5	5
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.05%	1.07%	1.12%	1.01%	1.00%	1.02%	1.03%	1.02%	0.99%	1.02%	1.08%	1.00%	1.23%	1.60%	0.94%	1.03%	0.99%

SI-BONE's average Quarter revenue forecast for Dec 23 based on 4 analysts is $37.92M, with a low forecast of $37.60M, and a high forecast of $38.42M. SIBN's average Quarter revenue forecast represents a 11.47% increase compared to the company's last Quarter revenue of $34.01M (Sep 23).

SI-BONE EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	6	3	2	2	4	2	2	2	1	1	1	1	2	2	2	6	9	9	9	9	5	5
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-11.17M	$-10.36M	$-10.29M	$-10.29M	$-13.40M	$-17.89M	$-16.14M	$-13.26M	$-12.62M	$-12.40M	$-10.84M	$-7.55M	$-8.09M	$-9.53M	$-11.29M	$-7.65M	$-9.89M
Avg Forecast	$-27.90M	$-25.61M	$-25.30M	$-24.91M	$-24.89M	$-21.94M	$-21.56M	$-20.53M	$-21.54M	$-18.60M	$-17.97M	$-15.46M	$-17.42M	$-14.88M	$-14.34M	$-14.05M	$-13.09M	$-12.82M	$-12.21M	$-12.77M	$-11.98M	$-10.91M	$-10.55M	$-11.65M	$-10.71M	$-8.01M	$-4.26M	$-8.62M	$-9.36M	$-7.89M
High Forecast	$-27.67M	$-25.39M	$-25.09M	$-24.70M	$-24.68M	$-21.76M	$-21.38M	$-20.19M	$-21.47M	$-18.60M	$-17.97M	$-12.36M	$-17.28M	$-14.88M	$-14.22M	$-11.24M	$-10.47M	$-12.82M	$-12.21M	$-10.22M	$-11.98M	$-10.91M	$-10.55M	$-9.32M	$-10.71M	$-8.01M	$-4.26M	$-6.89M	$-9.36M	$-7.89M
Low Forecast	$-28.27M	$-25.94M	$-25.63M	$-25.24M	$-25.22M	$-22.23M	$-21.85M	$-20.88M	$-21.67M	$-18.60M	$-17.97M	$-18.55M	$-17.65M	$-14.88M	$-14.53M	$-16.86M	$-15.71M	$-12.82M	$-12.21M	$-15.33M	$-11.98M	$-10.91M	$-10.55M	$-13.98M	$-10.71M	$-8.01M	$-4.26M	$-10.34M	$-9.36M	$-7.89M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.75%	0.72%	0.73%	0.79%	1.05%	1.47%	1.26%	1.11%	1.16%	1.18%	0.93%	0.70%	1.01%	2.24%	1.31%	0.82%	1.25%

undefined analysts predict SIBN's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than SI-BONE's previous annual EBITDA (undefined) of $NaN.

SI-BONE Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	6	3	2	2	4	2	2	2	1	1	1	1	2	2	2	6	9	9	9	9	5	5
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-10.02M	$-11.21M	$-10.12M	$-11.06M	$-14.75M	$-19.14M	$-17.95M	$-15.02M	$-15.87M	$-13.98M	$-12.24M	$-10.09M	$-9.47M	$-12.47M	$-12.77M	$-9.71M	$-11.31M
Avg Forecast	$-3.21M	$-4.76M	$-5.40M	$-6.27M	$-4.73M	$-5.96M	$-6.85M	$-8.05M	$-6.17M	$-9.97M	$-11.55M	$-16.66M	$-11.60M	$-14.29M	$-16.53M	$-15.14M	$-16.67M	$-19.58M	$-20.23M	$-13.77M	$-15.96M	$-17.24M	$-16.44M	$-13.16M	$-12.48M	$-16.00M	$-26.41M	$-9.75M	$-14.40M	$-15.39M
High Forecast	$-3.18M	$-4.71M	$-5.34M	$-6.20M	$-4.68M	$-5.90M	$-6.78M	$-6.13M	$-5.02M	$-9.86M	$-11.43M	$-13.33M	$-10.80M	$-14.13M	$-16.35M	$-12.11M	$-16.49M	$-19.58M	$-20.23M	$-11.01M	$-15.96M	$-17.24M	$-16.44M	$-10.53M	$-12.48M	$-16.00M	$-26.41M	$-7.80M	$-14.40M	$-15.39M
Low Forecast	$-3.27M	$-4.84M	$-5.49M	$-6.38M	$-4.81M	$-6.06M	$-6.97M	$-9.58M	$-7.33M	$-10.14M	$-11.75M	$-19.99M	$-12.40M	$-14.53M	$-16.81M	$-18.17M	$-16.96M	$-19.58M	$-20.23M	$-16.52M	$-15.96M	$-17.24M	$-16.44M	$-15.79M	$-12.48M	$-16.00M	$-26.41M	$-11.70M	$-14.40M	$-15.39M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.70%	0.68%	0.67%	0.66%	0.75%	0.95%	1.30%	0.94%	0.92%	0.85%	0.93%	0.81%	0.59%	0.47%	1.31%	0.67%	0.73%

SI-BONE's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. SIBN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

SI-BONE SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	6	3	2	2	4	2	2	2	1	1	1	1	2	2	2	6	9	9	9	9	5	5
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$34.22M	$35.29M	$34.79M	$34.68M	$32.74M	$36.52M	$32.74M	$32.74M	$29.72M	$29.64M	$26.86M	$25.31M	$23.69M	$19.91M	$24.68M	$24.47M	$23.26M
Avg Forecast	$75.58M	$69.36M	$68.52M	$67.47M	$67.42M	$59.43M	$58.41M	$55.62M	$58.36M	$50.39M	$48.67M	$31.33M	$47.19M	$40.30M	$38.85M	$28.48M	$39.21M	$32.90M	$31.33M	$27.22M	$30.75M	$27.99M	$27.06M	$23.56M	$27.48M	$20.55M	$10.93M	$22.23M	$24.00M	$20.24M
High Forecast	$76.58M	$70.28M	$69.43M	$68.36M	$68.31M	$60.21M	$59.18M	$56.55M	$58.69M	$50.39M	$48.67M	$37.59M	$47.81M	$40.30M	$39.36M	$34.18M	$39.72M	$32.90M	$31.33M	$27.22M	$30.75M	$27.99M	$27.06M	$23.56M	$27.48M	$20.55M	$10.93M	$22.23M	$24.00M	$20.24M
Low Forecast	$74.96M	$68.79M	$67.96M	$66.91M	$66.86M	$58.94M	$57.93M	$54.69M	$58.16M	$50.38M	$48.67M	$25.06M	$46.80M	$40.30M	$38.52M	$22.78M	$38.88M	$32.90M	$31.33M	$27.22M	$30.75M	$27.99M	$27.06M	$23.56M	$27.48M	$20.55M	$10.93M	$22.23M	$24.00M	$20.24M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.85%	0.91%	1.22%	0.88%	1.00%	1.17%	1.20%	1.06%	1.06%	1.10%	1.14%	0.92%	1.15%	1.82%	1.11%	1.02%	1.15%

SI-BONE's average Quarter SG&A projection for Dec 23 is $47.19M, based on 4 Wall Street analysts, with a range of $46.80M to $47.81M. The forecast indicates a 37.89% rise compared to SIBN last annual SG&A of $34.22M (Sep 23).

SI-BONE EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	6	3	2	2	4	2	2	2	1	1	1	1	2	2	2	6	9	9	9	9	5	5
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.25	$-0.30	$-0.29	$-0.32	$-0.43	$-0.56	$-0.53	$-0.45	$-0.56	$-0.45	$-0.39	$-0.32	$-0.36	$-0.52	$-0.50	$-0.39	$-0.49
Avg Forecast	$-0.08	$-0.11	$-0.13	$-0.15	$-0.11	$-0.14	$-0.16	$-0.19	$-0.15	$-0.24	$-0.28	$-0.31	$-0.28	$-0.34	$-0.40	$-0.41	$-0.40	$-0.47	$-0.49	$-0.43	$-0.39	$-0.42	$-0.40	$-0.40	$-0.30	$-0.39	$-0.64	$-0.38	$-0.35	$-0.37
High Forecast	$-0.08	$-0.11	$-0.13	$-0.15	$-0.11	$-0.14	$-0.16	$-0.15	$-0.12	$-0.24	$-0.27	$-0.31	$-0.26	$-0.34	$-0.39	$-0.41	$-0.40	$-0.47	$-0.49	$-0.43	$-0.39	$-0.42	$-0.40	$-0.40	$-0.30	$-0.39	$-0.64	$-0.38	$-0.35	$-0.37
Low Forecast	$-0.08	$-0.12	$-0.13	$-0.15	$-0.12	$-0.15	$-0.17	$-0.23	$-0.18	$-0.24	$-0.28	$-0.31	$-0.30	$-0.35	$-0.40	$-0.42	$-0.41	$-0.47	$-0.49	$-0.43	$-0.39	$-0.42	$-0.40	$-0.40	$-0.30	$-0.39	$-0.64	$-0.38	$-0.35	$-0.37
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.73%	0.76%	0.70%	0.80%	0.91%	1.14%	1.24%	1.16%	1.34%	1.13%	0.98%	1.06%	0.93%	0.81%	1.30%	1.12%	1.32%

According to undefined Wall Street analysts, SI-BONE's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to SIBN previous annual EPS of $NaN (undefined).

SI-BONE Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
RPID	Rapid Micro Biosystems	-	-	620.72%	Hold
SGHT	Sight Sciences	-	-	139.36%	Hold
LUNG	Pulmonx	-	-	85.83%	Buy
ESTA	Establishment Labs	-	-	83.06%	Buy
SIBN	SI-BONE	-	-	62.73%	Buy
RXST	RxSight	-	-	55.63%	Buy
KIDS	OrthoPediatrics	-	-	49.60%	Buy
NPCE	NeuroPace	-	-	43.11%	Buy
CNMD	CONMED	-	-	33.87%	Buy
OFIX	Orthofix Medical	-	-	28.48%
IRMD	IRadimed	-	-	12.72%	Buy
ITGR	Integer	-	-	1.56%	Buy
TCMD	Tactile Systems	-	-	0.38%	Buy

SIBN Forecast FAQ

Is SI-BONE a good buy?

Yes, according to 8 Wall Street analysts, SI-BONE (SIBN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 75.00% of SIBN's total ratings.

What is SIBN's price target?

SI-BONE (SIBN) average price target is $20 with a range of $18 to $25, implying a 62.73% from its last price of $12.29. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will SI-BONE stock go up soon?

According to Wall Street analysts' prediction for SIBN stock, the company can go up by 62.73% (from the last price of $12.29 to the average price target of $20), up by 103.42% based on the highest stock price target, and up by 46.46% based on the lowest stock price target.

Can SI-BONE stock reach $20?

SIBN's highest twelve months analyst stock price target of $25 supports the claim that SI-BONE can reach $20 in the near future.

What are SI-BONE's analysts' financial forecasts?

SI-BONE's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $193.54M (high $196.26M, low $191.56M), average EBITDA is $-88.922M (high $-88.011M, low $-90.17M), average net income is $-25.587M (high $-23.482M, low $-27.421M), average SG&A $240.87M (high $244.25M, low $238.41M), and average EPS is $-0.613 (high $-0.563, low $-0.657). SIBN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $225.73M (high $228.71M, low $223.86M), average EBITDA is $-104M (high $-103M, low $-105M), average net income is $-19.643M (high $-19.431M, low $-19.98M), average SG&A $280.94M (high $284.65M, low $278.61M), and average EPS is $-0.471 (high $-0.466, low $-0.479).

Did the SIBN's actual financial results beat the analysts' financial forecasts?

Based on SI-BONE's last annual report (Dec 2023), the company's revenue was $138.89M, beating the average analysts forecast of $130.68M by 6.28%. Apple's EBITDA was $-46.931M, missing the average prediction of $-60.689M by -22.67%. The company's net income was $-43.336M, missing the average estimation of $-57.561M by -24.71%. Apple's SG&A was $141.32M, missing the average forecast of $154.81M by -8.71%. Lastly, the company's EPS was $-0.0011, missing the average prediction of $-1.429 by -99.92%. In terms of the last quarterly report (Sep 2023), SI-BONE's revenue was $34.01M, beating the average analysts' forecast of $32.38M by 5.05%. The company's EBITDA was $-11.169M, missing the average prediction of $-14.877M by -24.92%. SI-BONE's net income was $-10.022M, missing the average estimation of $-14.286M by -29.85%. The company's SG&A was $34.22M, missing the average forecast of $40.3M by -15.07%. Lastly, the company's EPS was $-0.25, missing the average prediction of $-0.342 by -26.99%